Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.


Covid-19 Announcement

IDIFARMA is fully committed to the well-being of our employees, the quality of the services we provide to our valuable clients and our contribution to the general health of all people.


Idifarma will attend the following events during 2020 Would you like to meet us? Contact us at to schedule a meeting!


"@Idifarma is focused in providing our clients with the best technological solutions, so investing in GMP spray drying capabilities was the perfect fit for us" Manuel Leal, for the Magazine Outsourcing-Pharma.

Do you want to know more? Click here!

A very warm welcome to our new Head of Site, Alfredo Gomez!

With over 20 years’ experience in strategic operations within the pharmaceutical industry, Alfredo joins @Idifarma

Would you like to know more about this appointment? Click here!

“Our ability to manufacture highly potent drugs and small batches and our differentiating technologies, enable us to collaborate on projects involving innovative and hybrid drugs” Manuel Leal, Business Development Director of @Idifarma

Read all here!

Cipan-Companhia Industrial Produtora de Antibióticos, SA supported the Medical Emergency National Institute with the production of a solution of 2.660 L disinfectant gel and 5.480 L of ethanol 70% to fight the SARS-CoV-2.

Welcome to our quarterly #newsletter !
@Idifarma's current position in relation to #Covid19, new articles and interviews related to our #CDMO services and #technologies, and much more!

Would you like to read it? Click here

#Idifarma #CDMO #pharma

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies